Mycoprotein Market - Global Forecast 2025-2032

The mycoprotein market, driven by rising demand for sustainable and nutritious protein alternatives, is advancing rapidly across key regions and application segments. Leveraging proven fermentation technology, the sector now offers broad solutions for health-conscious consumers and industry stakeholders alike.

Market Snapshot: Growth, Innovation, and Competitive Dynamics

The Mycoprotein Market grew from USD 630.88 million in 2024 to USD 679.33 million in 2025. It is expected to continue growing at a CAGR of 8.51%, reaching USD 1.21 billion by 2032. This robust expansion reflects growing recognition of mycoprotein as an environmentally-efficient and nutritionally valuable protein source. Consumer health priorities, sustainability imperatives, and advances in biotechnology fuel adoption across retail, foodservice, and manufacturing channels.

Scope & Segmentation: Comprehensive Market Coverage

• Product Forms: Minced, Powder, Slices
• Grades: Feed Grade, Food Grade
• Distribution Channels: Offline (Convenience Stores, Speciality Stores, Super Markets/Hyper Markets), Online
• Applications: Animal Feed, Bakery Items, Meat Alternatives
• Geographical Scope: Americas (North America: United States, Canada, Mexico; Latin America: Brazil, Argentina, Chile, Colombia, Peru); Europe, Middle East & Africa (Europe: United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland; Middle East: United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel; Africa: South Africa, Nigeria, Egypt, Kenya); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
• Key Companies: 3F BIO GmbH, Aqua Cultured Foods, Bright Green Partners B.V., EniferBio Oy, Enough B.V., KIDEMIS GmbH, Maia Farms, Marlow Foods Limited, Meati Foods, Inc., Meatless B.V. by BENEO, Monde Nissin Corporation, Mycorena AB, MycoTechnology, Inc., Mycovation by The Trendlines Group., Nosh Biofoods GmbH, Quorn by Marlow Foods, Sustainable Superfoods by ACME Group, The Better Meat Co., The Fynder Group, Inc., Tyson Foods, Inc., Yutong Industrial Co., Limited

Key Takeaways for Senior Decision-Makers

• Mycoprotein is reaching mainstream adoption due to its favorable nutritional profile, ease of formulation, and sustainable production attributes relied upon by a broad range of stakeholders.
• Technology innovation in strain development and fermentation efficiency is improving yields, shortening production cycles, and enhancing end-product taste and texture to compete directly with traditional proteins.
• Consumers track provenance and sustainability, elevating transparency and traceability as pivotal for differentiation and brand loyalty, especially in premium and health-driven market segments.
• Market penetration is shaped by strong offline retail presence, with online distribution capturing digital-first buyers through curated, direct-to-consumer solutions and subscription models.
• B2B adoption of mycoprotein is expanding, with applications extending beyond consumer food to functional foods and supplements, positioning mycoprotein as a key foundation for future protein innovation.
• Collaborations—ranging from ingredient partnerships to joint ventures in emerging regions—are streamlining production, managing capacity, and accelerating access to new consumer and institutional channels.

Tariff Impact: Strategic Trade Shifts in 2025

The introduction of revised United States tariffs on imported mycoprotein in 2025 will drive up unit costs for importers and prompt reassessment of procurement strategies throughout the supply chain. Domestic producers are poised to benefit from increased demand but may require rapid scaling of facilities. Sector participants are expected to pursue strategic partnerships, alternative sourcing, and adaptive pricing models to manage volatility and maintain growth momentum amid evolving trade policies.

Methodology & Data Sources

This analysis combines primary interviews with stakeholders—including producers, retailers, and regulators—and rigorous secondary research from scientific, industry, and trade sources. Findings were further validated through triangulation and expert panel reviews, ensuring data reliability and practical insight for strategic planning in the global mycoprotein market.

Why This Report Matters

• Enables targeted investment and innovation by mapping essential product, channel, and regional trends shaping the next phase of the mycoprotein industry.
• Equips decision-makers to anticipate and adapt to supply chain, regulatory, and trade disruptions, safeguarding continuity and competitive edge.
• Informs effective go-to-market and procurement strategies across segments and geographies for sustained leadership in protein alternatives.

Conclusion

The mycoprotein market’s trajectory is driven by innovation, sustainability alignment, and region-specific adoption trends. Equipped with strategic insights, businesses can optimize growth and navigate evolving market and trade complexities with confidence.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.